Looking for Sentiment Analysis? Discover the most popular stocks on Reddit by using our Sentiment Tracker
Market Cap 3.64B P/E 21.80 EPS this Y -21.00% Ern Qtrly Grth -
Income 23.65M Forward P/E 12.67 EPS next Y 2.40% 50D Avg Chg 6.00%
Sales 1.57B PEG 1.13 EPS past 5Y 3.81% 200D Avg Chg -13.00%
Dividend N/A Price/Book 2.15 EPS next 5Y 6.30% 52W High Chg -27.00%
Recommedations 3.20 Quick Ratio 1.75 Shares Outstanding 77.58M 52W Low Chg 19.00%
Insider Own 3.19% ROA 3.51% Shares Float 66.44M Beta 1.10
Inst Own 95.12% ROE 1.47% Shares Shorted/Prior 4.57M/4.79M Price 44.48
Gross Margin 59.97% Profit Margin 1.51% Avg. Volume 817,158 Target Price 27.56
Oper. Margin 11.28% Earnings Date Oct 23 Volume 861,998 Change -1.05%
About Integra LifeSciences Holdings C

Integra LifeSciences Holdings Corporation manufactures and sells surgical instruments, neurosurgical products, and wound care products for use in neurosurgery, neurocritical care, and otolaryngology. It operates in two segments, Codman Specialty Surgical and Tissue Technologies. The company offers neurosurgery and neuro critical care products, including tissue ablation equipment, dural repair products, cerebral spinal fluid management devices, intracranial monitoring equipment, and cranial stabilization equipment; and surgical headlamps and instrumentation, as well as after-market services. It also sells instrument patterns, and surgical and lighting products to hospitals and surgery centers, as well as dental, podiatry, and veterinary offices. In addition, the company provides regenerative technology products for the treatment of acute wounds; and surgical tissue repair products for hernia, tendon, peripheral nerve repair and protection. Further, it offers skin and wound repair, plastics and surgical reconstruction products, bone grafts, and nerve and tendon repair products. The company offers its products directly through various sales forces and other distribution channels to the hospitals, integrated health networks, group purchasing organizations, clinicians, surgery centers, and health care providers in the United States, Europe, Asia Pacific, and internationally. Integra LifeSciences Holdings Corporation was incorporated in 1989 and is headquartered in Princeton, New Jersey.

Integra LifeSciences Holdings C News
10:10 AM Insider Stock Buying Reaches US$2.50m On Integra LifeSciences Holdings
12/19/24 Here’s Why Integra LifeSciences Holdings Corporation (IART) Fell in Q3
12/04/24 Integra (IART) Down 1.1% Since Last Earnings Report: Can It Rebound?
11/25/24 Reasons to Retain IART Stock in Your Portfolio for Now
11/14/24 IART Stock to Gain From New Study Findings on DuraSeal Dural Sealant
11/13/24 Integra’s DuraSeal® Dural Sealant Saves Healthcare Costs According to an Economic Evaluation Published in the Journal of Comparative Effectiveness Research
11/06/24 Integra LifeSciences price target raised to $22 from $16 at Citi
11/05/24 Integra Q3 Earnings, Revenues Beat, Stock Up Despite Margin Pressure
11/05/24 Integra LifeSciences Holdings Third Quarter 2024 Earnings: Revenues Beat Expectations, EPS Lags
11/05/24 Integra Lifesciences Holdings Corp (IART) Q3 2024 Earnings Call Highlights: Navigating ...
11/05/24 Q3 2024 Integra Lifesciences Holdings Corp Earnings Call
11/05/24 Integra Lifesciences names Mojdeh Poul as CEO
11/04/24 Why Is Integra LifeSciences Stock Soaring On Monday?
11/04/24 Integra (IART) Reports Q3 Earnings: What Key Metrics Have to Say
11/04/24 Integra LifeSciences (IART) Beats Q3 Earnings and Revenue Estimates
11/04/24 Integra: Q3 Earnings Snapshot
11/04/24 Is Integra LifeSciences Holdings Corporation (NASDAQ:IART) Potentially Undervalued?
11/04/24 Integra LifeSciences Reports Third Quarter 2024 Financial Results
11/04/24 Integra LifeSciences Announces Appointment of Mojdeh Poul as President and Chief Executive Officer
10/14/24 Integra LifeSciences to Host Third Quarter 2024 Financial Results Conference Call on November 4, 2024
Insider Trades Relationship Date Transactions Cost($) #Shares Value($) #Share Own SEC Form 4
McBreen Michael J. EVP & President, CSS EVP & President, CSS Mar 07 Sell 54.2943 1,843 100,064 28,796 03/08/23
DAVIS ROBERT T. JR. EVP & President, TT EVP & President, TT Mar 01 Sell 55.21 1,566 86,459 45,920 03/03/23
DAVIS ROBERT T. JR. EVP & President, TT EVP & President, TT Mar 01 Option 26.87 1,566 42,078 47,486 03/03/23
Mosebrook Jeffrey SVP, Fin & Princ Acc.. SVP, Fin & Princ Acct Officer Dec 08 Sell 56.2162 279 15,684 8,552 12/08/22
Evoli Lisa Executive Vice Presi.. Executive Vice President &CHRO Aug 10 Sell 55.8108 1,165 65,020 17,997 08/11/22
Murphy Raymond G. Director Director Aug 05 Sell 55.7833 8,000 446,266 40,825 08/08/22
Mosebrook Jeffrey SVP, Fin & Princ Acc.. SVP, Fin & Princ Acct Officer Aug 02 Sell 56.775 437 24,811 8,831 08/03/22
Evoli Lisa Executive Vice Presi.. Executive Vice President &CHRO Jun 15 Sell 55.93 900 50,337 19,911 06/16/22
Tru St Partnership, L.P. 10% Owner 10% Owner Dec 16 Sell 64.92 300,000 19,476,000 8,515,930 03/25/22
McBreen Michael J. EVP & President, CSS EVP & President, CSS Mar 03 Sell 69 2,205 152,145 17,233 03/03/21
Arduini Peter J President & CEO President & CEO Dec 21 Option 15.79 45,000 710,550 261,713 12/21/20
Arduini Peter J President & CEO President & CEO Dec 21 Sell 61.97 45,000 2,788,650 216,713 12/21/20
Coleman Glenn Executive Vice Presi.. Executive Vice President & COO Nov 12 Sell 55.14 9,400 518,316 36,494 11/12/20